MedPath

上海新亚药业闵行有限公司

Ownership
-
Established
1989-07-06
Employees
-
Market Cap
-
Website
http://www.shec.gov.cn/xymh/xy1.htm

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

NMPA:99

Drug Approvals

林可霉素维B6乳膏

Approval Number
国药准字H31022290
Approval Date
Jul 30, 2024
NMPA

复方醋酸曲安奈德溶液

Approval Number
国药准字H31022713
Approval Date
Jul 22, 2024
NMPA

头孢氨苄胶囊

Approval Number
国药准字H31020756
Approval Date
Jul 22, 2024
NMPA

盐酸洛哌丁胺胶囊

Approval Number
国药准字H10900078
Approval Date
Jul 22, 2024
NMPA

盐酸克林霉素乳膏

Approval Number
国药准字H20080363
Approval Date
Jul 22, 2024
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H31020232
Approval Date
Jul 22, 2024
NMPA

硫酸庆大霉素胶囊

Approval Number
国药准字H20053250
Approval Date
Jul 22, 2024
NMPA

土霉素片

Approval Number
国药准字H31020017
Approval Date
Jul 22, 2024
NMPA

Chloramphenicol Capsules

Product Name
氯霉素胶囊
Approval Number
国药准字H31021079
Approval Date
Jun 18, 2024
NMPA

Tolbutamide Tablets

Product Name
甲苯磺丁脲片
Approval Number
国药准字H31020357
Approval Date
Jun 18, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.